Abstract
Faced with the problem of giving individualised advice about adjuvant chemotherapy to patients who have had an apparently curative lung cancer resection, we propose a model to help clarify the choices being made. This would inform the clinician, help the patient and be an explicit basis on which to initiate the discussion.
Publication types
-
Meta-Analysis
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / pathology
-
Carcinoma, Non-Small-Cell Lung / surgery*
-
Chemotherapy, Adjuvant
-
Decision Making*
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / pathology
-
Lung Neoplasms / surgery*
-
Models, Theoretical
-
Neoplasm Staging
-
Pneumonectomy*
-
Research Design
-
Survival Analysis
-
Treatment Outcome